
New results and forthcoming EORTC trials in prostate cancer, melanoma, head and neck, lung, rare, and breast cancers presented at ESMO 2024
17 Sep 2024

Late Breaking Results from the EORTC 1333/PEACE III phase III trial
16 Sep 2024

EORTC’s presence at ESMO 2024
10 Sep 2024

Meet the new EORTC Board
9 Jul 2024

We are pleased to announce the release of the EORTC 2023 Annual Report
17 Jun 2024

Dr Denis Lacombe, EORTC CEO, appointed stakeholder co-chair of ACT EU advisory group
24 May 2024

Clinical Trials Day 2024: a Q&A on pragmatic clinical trials
20 May 2024

EORTC/EMA workshop suggests an international way forward for treatment optimisation studies
8 May 2024